Yersinia pestis caf1 variants and the limits of plague vaccine protection

Infection and Immunity

Volumn 76, Issue 5, 2008, Pages 2025-2036

  Quenee, Lauriane E ^a   Cornelius, Claire A ^a   Ciletti, Nancy A ^a   Elli, Derek ^a   Schneewind, Olaf ^a,b  

^a UNIVERSITY OF CHICAGO   (United States)

^b Department of Microbiology ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIVE VACCINE; SUBUNIT VACCINE; BACTERIAL ANTIGEN; BACTERIAL PROTEIN; BACTERIUM ANTIBODY; CAF1 PROTEIN, YERSINIA PESTIS; IMMUNOGLOBULIN G; LCRV PROTEIN, YERSINIA; PLAGUE VACCINE; PORE FORMING CYTOTOXIC PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FEMALE; GENETIC VARIABILITY; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNITY; IMMUNIZATION; MOUSE; MUTANT; NONHUMAN; PARASITE VIRULENCE; PLAGUE; PRIORITY JOURNAL; WILD TYPE; YERSINIA PESTIS; ANIMAL; BACTERIAL COUNT; BAGG ALBINO MOUSE; BLOOD; GENE DELETION; GENETICS; IMMUNOLOGY; LUNG; MICROBIOLOGY; PATHOLOGY; SPLEEN; SURVIVAL; VIRULENCE;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; COLONY COUNT, MICROBIAL; FEMALE; GENE DELETION; IMMUNOGLOBULIN G; LUNG; MICE; MICE, INBRED BALB C; PLAGUE; PLAGUE VACCINE; PORE FORMING CYTOTOXIC PROTEINS; SPLEEN; SURVIVAL ANALYSIS; VACCINES, ATTENUATED; VIRULENCE; YERSINIA PESTIS;

EID: 42949122122     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.00105-08     Document Type: Article

References (62)

1. Anderson, G. W., Jr., S. E. C. Leary, E. D. Williamson, R. C. Titball, S. C. Welkos, P. L. Worsham, and A. M. Friedlander. 1996. Recombinant V antigen protects mice against pneumonic and bubonic plague caused by F1-capsule-positive and -negative strains of Yersinia pestis. Infect. Immun. 64:4580-4585.
2. Andrews, G. P., D. G. Heath, G. W. Anderson, Jr., S. L. Welkos, and A. M. Friedlander. 1996. Fraction 1 capsular antigen (F1) purification from Yersinia pestis CO92 and from an Escherichia coli recombinant strain and efficacy against lethal plague challenge. Infect. Immun. 64:2180-2187.
3. Anisimov, A., L. Lindler, and G. Pier. 2004. Intraspecific diversity of Yersinia pestis. Clin. Microbiol. Rev. 17:434-464.
4. Bach, S., C. Buchrieser, M. Prentice, A. Guiyoule, T. Msadek, and E. Carniel. 1999. The high-pathogenicity island of Yersinia enterocolitica Ye8081 undergoes low-frequency deletion but not precise excision, suggesting recent stabilization in the genome. Infect. Immun. 67:5091-5099.
5. Baker, E. E., H. Sommer, L. W. Foster, E. Meyer, and K. F. Meyer. 1952. Studies on immunization against plague. I. The isolation and characterization of the soluble antigen of Pasteurella pestis. J. Immunol. 68:131-145.
6. Bearden, S., J. Fetherston, and R. Perry. 1997. Genetic organization of the yersiniabactin biosynthetic region and construction of avirulent mutants in Yersinia pestis. Infect. Immun. 65:1659-1668.
7. Boisier, P., L. Rahalison, M. Rasolomaharo, M. Ratsitorahina, M. Mahafaly, M. Razafimahefa, J.-M. Duplantier, L. Ratsifasomanana, and S. Chanteau. 2002. Epidemiologic features of four successive annual outbreaks of bubonic plague in Mahajanga, Madagascar. Emerg. Infect. Dis. 8:311-316.
8. Brubaker, R. R. 1969. Mutation rate to nonpigmentation in Pasteurella pestis. J. Bacteriol. 98:1404-1406.
9. Buchrieser, C., C. Rusniok, L. Frangeul, E. Couve, A. Billault, F. Kunst, E. Carniel, and P. Glaser. 1999. The 102-kilobase pgm locus of Yersinia pestis: sequence analysis and comparison of selected regions among different Yersinia pestis and Yersinia pseudotuberculosis strains. Infect. Immun. 67:4851-4861.
10. Burrows, T. W. 1956. An antigen determining virulence in Pasteurella pestis. Nature 177:426-427.
11. Burrows, T. W. 1963. Virulence of Pasteurella pestis and immunity to plague. Ergebn. Mikrobiol. 37:59-113.
12. Burrows, T. W., and G. A. Bacon. 1956. The basis of virulence in Pasteurella pestis: antigen determining virulence. Br. J. Exp. Pathol. 37:481-493.
13. Burrows, T. W., and G. A. Bacon. 1958. The effect of loss of different virulence determinants on the virulence and immunogenicity of strains of Pasteurella pestis. Br. J. Exp. Pathol. 39:278-291.
14. Cheng, L. W., D. M. Anderson, and O. Schneewind. 1997. Two independent type III secretion mechanisms for YopE in Yersinia enterocolitica. Mol. Microbiol. 24:757-765.
15. Davis, K. J., D. L. Fritz, M. L. M. Pitt, S. L. Welkos, P. L. Worsham, and A. M. Friedlander. 1996. Pathology of experimental pneumonic plague produced by fraction 1-positive and fraction 1-negative Yersinia pestis in African green monkeys (Cercopitheus aethiops). Arch. Pathol. Lab. Med. 120:156-163.
16. DeBord, K., V. T. Lee, and O. Schneewind. 2001. On the role of LcrG and LcrV during the type III targeting of effector Yops by Yersinia enterocolitica. J. Bacteriol. 183:4588-4598.
17. DeBord, K. L., D. M. Anderson, M. M. Marketon, K. A. Overheim, R. W. DePaolo, N. A. Ciletti, B. Jabri, and O. Schneewind. 2006. Immunogenicity and protective immunity against bubonic and pneumonic plague by immunization of mice with the recombinant V10 antigen, a variant of LcrV. Infect. Immun. 74:4910-4914.
18. Deng, W., V. Burland, G. R. Plunkett, A. Boutin, G. F. Mayhew, P. Liss, N. T. Perna, D. J. Rose, B. Mau, S. Zhou, D. C. Schwartz, J. D. Fetherston, L. E. Lindler, R. R. Brubaker, G. V. Plano, S. C. Straley, K. A. McDonough, M. L. Nilles, J. S. Matson, F. R. Blattner, and R. D. Perry. 2002. Genome sequence of Yersinia pestis KIM. J. Bacteriol. 184:4601-4611.
19. Du, Y., R. Rosqvist, and A. Forsberg. 2002. Role of fraction 1 antigen of Yersinia pestis in inhibition of phagocytosis. Infect. Immun. 70:1453-1460.
20. Fetherston, J. D., P. Schuetze, and R. D. Perry. 1992. Loss of the pigmentation phenotype in Yersinia pestis is due to the spontaneous deletion of 102 kb of chromosomal DNA which is flanked by a repetitive element. Mol. Microbiol. 6:2693-2704.
21. Filippov, A. A., N. S. Solodovnikov, L. M. Kookleva, and O. A. Protsenko. 1990. Plasmid content in Yersinia pestis strains of different origin. FEMS Microbiol. Lett. 67:45-48.
22. Friedlander, A. M., S. L. Welkos, P. L. Worsham, G. P. Andrews, D. G. Heath, G. W. Anderson, Jr., L. M. Pitt, J. Estep, and K. Davis. 1995. Relationship between virulence and immunity as revealed in recent studies of the F1 capsule of Yersinia pestis. Clin. Infect. Dis. 21:S178-S181.
23. Galyov, E. E., O. Y. Smirnov, A. V. Karlishev, K. I. Volkovoy, A. I. Denesyuk, I. V. Nazimov, K. S. Rubtsov, V. M. Abramov, S. M. Dalvadyanz, and V. P. Zav'yalov. 1990. Nucleotide sequence of the Yersinia pestis gene encoding F1 antigen and the primary structure of the protein. Putative T and B cell epitopes. FEBS Lett. 17:230-232.
24. Girard, G. 1955. Plague. Annu. Rev. Microbiol. 9:253-277.
25. Girard, G., and J. Robic. 1942. L'état actuel de la peste à Madagascar et la prophylaxie vaccinale par le virus-vaccin E. V. Bull. Soc. Pathol. Exot. 35:42-49.
26. Gottfried, R. S. 1983. The black death. Natural and human disaster in medieval Europe. The Free Press, New York, NY.
27. Haffkine, W. M. 1897. Remarks on the plague prophylactic fluid. Br. Med. J. 1:1461-1462.
28. Heath, D. G., G. W. Anderson, Jr., J. M. Mauro, S. L. Welkos, G. P. Andrews, J. J. Adamovicz, and A. M. Friedlander. 1998. Protection against experimental bubonic and pneumonic plague by a recombinant capsular F1-V antigen fusion protein vaccine. Vaccine 16:1131-1137.
29. Heilmann, C., O. Schweitzer, C. Gerke, N. Vanittanakom, D. Mack, and F. Gotz. 1996. Molecular basis of intercellular adhesion in the biofilm-forming Staphylococcus epidermidis. Mol. Microbiol. 20:1083-1091.
30. Inglesby, T. V., D. T. Dennis, D. A. Henderson, J. G. Bartlett, M. S. Ascher, E. Eitzen, A. D. Fine, A. M. Friedlander, J. Hauer, J. F. Koerner, M. Layton, J. McDade, M. T. Osterholm, T. O'Toole, G. Parker, T. M. Perl, P. K. Russell, M. Schoch-Spana, and K. Tonat. 2000. Plague as a biological weapon: medical and public health management. JAMA 283:2281-2290.
31. Kellogg, W. H. 1920. An epidemic of pneumonic plague. Am. J. Public Health 10:599-605.
32. Kirillina, O., J. D. Fetherston, A. G. Bobrov, J. Abney, and R. D. Perry. 2004. HmsP, a putative phosphodiesterase, and HmsT, a putative diguanylate cyclase, control Hms-dependent biofilm formation in Yersinia pestis. Mol. Microbiol. 54:75-88.
33. Leary, S. E. C., E. D. Williamson, K. F. Griffin, P. Russell, S. M. Eley, and R. W. Titball. 1995. Active immunization with recombinant V antigen from Yersinia pestis protects mice against plague. Infect. Immun. 63:2854-2858.
34. Lillard, J. W., Jr., S. W. Bearden, J. D. Fetherston, and R. D. Perry. 1999. The haemin storage (Hms+) phenotype of Yersinia pestis is not essential for the pathogenesis of bubonic plague in mammals. Microbiology 145:197-209.
35. Lindler, L. E., G. V. Plano, V. Burland, G. F. Mayhew, and F. R. Blattner. 1998. Complete DNA sequence and detailed analysis of the Yersinia pestis KIM 5 plasmid encoding murine toxin and capsular antigen. Infect. Immun. 66:5731-5742.
36. Meyer, K. 1961. Pneumonic plague. Bacteriol. Rev. 25:249-261.
37. Meyer, K. F. 1970. Effectiveness of live or killed plague vaccines in man. Bull. W. H. O. 42:653-666.
38. Meyer, K. F., D. C. Cavanaugh, P. J. Bartonelli, and J. Marshall, J. D. 1974. Plague immunization. Part I. Past and present trends. J. Infect. Dis. 129:S13-S18.
39. Meyer, K. F., G. Smith, L. E. Foster, J. D. Marshall, and D. C. Cavanaugh. 1974. Plague immunization. IV. Clinical reactions and serological responses to inoculations of Haffkine and freeze-dried plague vaccine. J. Infect. Dis. 129:S30-S36.
40. Miller, J., E. D. Williamson, J. H. Lakey, M. J. Pearce, S. M. Jones, and R. W. Titball. 1998. Macromolecular organisation of recombinant Yersinia pestis F1 antigen and the effect of structure on immunogenicity. FEMS Immunol. Med. Microbiol. 21:213-221.
41. Motin, V. L., R. Nakajima, G. B. Smirnov, and R. R. Brubaker. 1994. Passive immunity to yersiniae mediated by anti-recombinant V antigen and protein A-V antigen fusion peptide. Infect. Immun. 62:4192-4201.
42. Motin, V. L., Y. A. Nedialkov, and R. R. Brubaker. 1996. V antigen-polyhistidine fusion peptide: binding to LcrH and active immunity against plague. Infect. Immun. 64:4313-4318.
43. Mueller, C. A., P. Broz, S. A. Muller, P. Ringler, F. Erne-Brand, I. Sorg, M. Kuhn, A. Engel, and G. R. Cornelis. 2005. The V-antigen of Yersinia forms a distinct structure at the tip of injectisome needles. Science 310:674-676.
44. Naphny, W., and A. Spicer. 2004. Plague: black death and pestilence in Europe. Tempus, Stroud, Gloucestershire, United Kingdom.
45. Parkhill, J., B. W. Wren, N. R. Thompson, R. W. Titball, M. T. Holden, M. B. Prentice, M. Sebaihia, K. D. James, C. Churcher, K. L. Mungall, S. Baker, D. Dasham, S. D. Bentley, K. Brooks, A. M. Cerdeno-Tarraga, T. Chillingworth, A. Cronin, R. M. Davies, P. Davis, G. Dougan, T. Feltwell, N. Hamlin, S. Holroyd, K. Jagels, A. V. Kariyshev, S. Leather, S. Moule, P. C. Oyston, M. Quail, K. Rutherford, M. Simmonds, J. Skelton, K. Stevens, S. Whitehead, and B. G. Barrell. 2001. Genome sequence of Yersinia pestis, the causative agent of plague. Nature 413:523-527.
46. Perry, R. D., P. B. Balbo, H. A. Jones, J. D. Fetherston, and E. DeMoll. 1999. Yersiniabactin from Yersinia pestis: biochemical characterization of the siderophore and its role in iron transport and regulation. Microbiology 145:1181-1190.
47. Perry, R. D., and J. D. Fetherston. 1997. Yersinia pestis: etiologic agent of plague. Clin. Microbiol. Rev. 10:35-66.
48. 2+ response operon encodes the V antigen of Yersinia pestis. Infect. Immun. 54:428-434.
49. 2+-response plasmid pCD1 of Yersinia pestis KIM 5. Infect. Immun. 66:4611-4623.
50. Ratsitorahina, M., S. Chanteau, L. Rahalison, L. Ratisofasoamanana, and P. Boisier. 2000. Epidemiological and diagnostic aspects of the outbreak of pneumonic plague in Madagascar. Lancet 355:111-113.
51. Russel, P., S. M. Eley, S. E. Hibbs, R. J. Manchee, A. J. Stagg, and R. W. Titball. 1995. A comparison of plague vaccine, USP and EV76 vaccine induced protection against Yersinia pestis in a murine model. Vaccine 13:1551-1556.
52. Simonet, M., P. Berche, D. Mazigh, and M. Veron. 1985. Protection against Yersinia infection induced by non-virulence-plasmid-encoded antigens. J. Med. Microbiol. 20:225-231.
53. Slack, P. 1989. The black death, past and present. Trans. R. Soc. Trop. Med. Hyg. 83:461-463.
54. Taylor, V. L., R. W. Titball, and P. C. F. Oyston. 2005. Oral immunization with a dam mutant of Yersinia pseudotuberculosis protects against plague. Microbiology 151:1919-1926.
55. Titball, R. W., and E. D. Williamson. 2001. Vaccination against bubonic and pneumonic plague. Vaccine 19:4175-4184.
56. Titball, R. W., and E. D. Williamson. 2004. Yersinia pestis (plague) vaccines. Expert Opin. Biol. Ther. 4:965-973.
57. Welkos, S. L., G. P. Andrews, L. E. Lindler, N. J. Snellings, and S. D. Strachan. 2004. Mu dI1(Ap lac) mutagenesis of Yersinia pestis plasmid pFra and identification of temperature-regulated loci associated with virulence. Plasmid 51:1-11.
58. Welkos, S. L., K. M. Davis, L. M. Pitt, P. L. Worsham, and A. M. Friedlander. 1995. Studies on the contribution of the F1 capsule-associated plasmid pFra to the virulence of Yersinia pestis. Contrib. Microbiol. Immunol. 13:299-305.
59. Williamson, E. D., S. M. Eley, A. J. Stagg, M. Green, P. Russell, and R. W. Titball. 1997. A sub-unit vaccine elicits IgG in serum, spleen cell cultures and bronchial washings and protects immunized animals against pneumonic plague. Vaccine 15:1079-1084.
60. Williamson, E. D., H. C. Flick-Smith, C. LeButt, C. A. Rowland, S. M. Jones, E. L. Waters, R. J. Gwyther, J. Miller, P. J. Packer, and M. Irving. 2005. Human immune response to a plague vaccine comprising recombinant F1 and V antigens. Infect. Immun. 73:3598-3608.
61. Worsham, P. L., M. P. Stein, and S. L. Welkos. 1995. Construction of defined F1 negative mutants of virulent Yersinia pestis. Contrib. Microbiol. Immunol. 13:325-328.
62. Zavialov, A. V., J. Berglund, A. F. Pudney, L. J. Fooks, T. M. Ibrahim, S. MacIntyre, and S. D. Knight. 2003. Structure and biogenesis of the capsular F1 antigen from Yersinia pestis: preserved folding energy drives fiber formation. Cell 113:587-596.